RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product
/
DateMar 17 2025
The Company Received Approval in Multiple European Countries to Initiate this Key Study Necessary for Commercial Product Approval LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it... Read More →